Mathers Edward T
Insider CIK 1328625 · SVRA 10% owner · LQDA Director · RARX Director · MIRN Director · TRVI Director · OKUR Director · RYTM Director · BHG Director, 10% owner · INZY Director · KRRO 10% owner · AKUS Director · MIRM Director · MBX Director, 10% owner · SGP 10% owner · GLUE 10% owner · SNTI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 22,350 | — | $0 | 22,350 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 22,350 | — | $0 | 22,350 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award deriv | 2026-06-04 | 2026-06-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-06-04 | 2026-06-08 | 7,650 | — | $0 | 7,650 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2026-06-03 | 2026-06-04 | 35,000 | — | $0 | 35,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | J Other | 2026-03-12 | 2026-03-16 | 4,199 | — | $0 | 14,168 | SEC↗ |
| KRRO Korro Bio, Inc. | P Buy deriv | 2026-03-10 | 2026-03-12 | 242,945 | $11.11 | $2.70M | 242,945 | SEC↗ |
| KRRO Korro Bio, Inc. | P Buy | 2026-03-10 | 2026-03-12 | 207,100 | $11.11 | $2.30M | 1,297,893 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | J Other | 2026-03-02 | 2026-03-04 | 4,198 | — | $0 | 9,969 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 737,962 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 1,619,240 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 1,370,168 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 1,370,168 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 1,619,240 | — | $0 | 1,619,240 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 1,370,168 | — | $0 | 2,989,408 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 1,370,168 | — | $0 | 4,359,576 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 737,962 | — | $0 | 5,097,538 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | P Buy | 2026-02-09 | 2026-02-11 | 937,500 | $16.00 | $15.00M | 6,035,038 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award | 2025-12-31 | 2026-01-02 | 3,911 | — | $0 | 15,310 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise deriv | 2025-10-02 | 2025-10-06 | 1,656,789 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | A Award deriv | 2025-10-02 | 2025-10-06 | 186,128 | — | $0 | 186,128 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise deriv | 2025-10-02 | 2025-10-06 | 186,128 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer deriv | 2025-10-02 | 2025-10-06 | 75,000 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer deriv | 2025-10-02 | 2025-10-06 | 37,700 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise deriv | 2025-10-02 | 2025-10-06 | 189,195 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise deriv | 2025-10-02 | 2025-10-06 | 607,536 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | A Award deriv | 2025-10-02 | 2025-10-06 | 124,085 | — | $0 | 124,085 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise deriv | 2025-10-02 | 2025-10-06 | 124,085 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer deriv | 2025-10-02 | 2025-10-06 | 125,000 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer deriv | 2025-10-02 | 2025-10-06 | 100,000 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise | 2025-10-02 | 2025-10-06 | 124,085 | $0.01 | $1.2K | 2,385,055 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer | 2025-10-02 | 2025-10-06 | 674,554 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise | 2025-10-02 | 2025-10-06 | 1,656,789 | $0.01 | $16.6K | 1,656,789 | SEC↗ |
| NEUE NeueHealth, Inc. | S Sale | 2025-10-02 | 2025-10-06 | 2,455 | $6.75 | $16.6K | 1,654,334 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise | 2025-10-02 | 2025-10-06 | 607,536 | $0.01 | $6.1K | 2,261,870 | SEC↗ |
| NEUE NeueHealth, Inc. | S Sale | 2025-10-02 | 2025-10-06 | 900 | $6.75 | $6.1K | 2,260,970 | SEC↗ |
| NEUE NeueHealth, Inc. | F Tax w/h | 2025-10-02 | 2025-10-06 | 276 | $6.75 | $1.9K | 674,554 | SEC↗ |
| NEUE NeueHealth, Inc. | F Tax w/h | 2025-10-02 | 2025-10-06 | 182 | $6.75 | $1.2K | 2,384,873 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer | 2025-10-02 | 2025-10-06 | 2,384,873 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise | 2025-10-02 | 2025-10-06 | 189,195 | $0.01 | $1.9K | 488,982 | SEC↗ |
| NEUE NeueHealth, Inc. | S Sale | 2025-10-02 | 2025-10-06 | 280 | $6.75 | $1.9K | 488,702 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise | 2025-10-02 | 2025-10-06 | 186,128 | $0.01 | $1.9K | 674,830 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award | 2025-09-30 | 2025-10-02 | 4,125 | — | $0 | 11,399 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award | 2025-06-30 | 2025-07-02 | 4,694 | — | $0 | 7,274 | SEC↗ |
| SNTI Senti Biosciences, Inc. | A Award deriv | 2025-06-25 | 2025-06-27 | 21,950 | — | $0 | 21,950 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2025-06-24 | 2025-06-26 | 4,712 | — | $0 | 4,712 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2025-06-24 | 2025-06-26 | 7,037 | — | $0 | 7,037 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2025-06-18 | 2025-06-23 | 4,000 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2025-06-18 | 2025-06-23 | 4,000 | — | $0 | 7,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-13 | 45,000 | — | $0 | 45,000 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award deriv | 2025-06-05 | 2025-06-06 | 16,000 | — | $0 | 16,000 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 7,650 | — | $0 | 7,650 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award | 2025-03-31 | 2025-04-02 | 2,580 | — | $0 | 2,580 | SEC↗ |
| SNTI Senti Biosciences, Inc. | A Award deriv | 2025-03-07 | 2025-03-11 | 43,900 | — | $0 | 43,900 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2024-10-04 | 2024-10-08 | 15,300 | — | $0 | 15,300 | SEC↗ |
| NEUE NeueHealth, Inc. | P Buy deriv | 2024-10-01 | 2024-10-03 | 61,865 | — | $0 | 185,594 | SEC↗ |
| NEUE NeueHealth, Inc. | P Buy deriv | 2024-10-01 | 2024-10-03 | 185,595 | — | $0 | 556,782 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 25,142,840 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 12,299,854 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2024-09-16 | 2024-09-17 | 500,000 | $16.00 | $8.00M | 3,614,486 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion | 2024-09-16 | 2024-09-17 | 2,091,383 | — | $0 | 3,114,486 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion | 2024-09-16 | 2024-09-17 | 1,023,103 | — | $0 | 1,023,103 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award deriv | 2024-09-12 | 2024-09-13 | 15,963 | — | $0 | 15,963 | SEC↗ |
| SNTI Senti Biosciences, Inc. | A Award deriv | 2024-07-10 | 2024-07-12 | 62,500 | — | $0 | 62,500 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2024-06-21 | 2024-06-25 | 3,000 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2024-06-21 | 2024-06-25 | 3,000 | — | $0 | 3,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2024-06-18 | 2024-06-20 | 28,000 | — | $0 | 28,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2024-06-18 | 2024-06-20 | 14,000 | — | $0 | 14,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2024-06-18 | 2024-06-20 | 4,000 | — | $0 | 4,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2024-06-13 | 2024-06-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KRRO Korro Bio, Inc. | P Buy | 2024-04-22 | 2024-04-24 | 17,857 | $56.00 | $1000.0K | 1,090,793 | SEC↗ |
| NEUE NeueHealth, Inc. | P Buy deriv | 2024-04-08 | 2024-04-10 | 123,729 | — | $0 | 123,729 | SEC↗ |
| NEUE NeueHealth, Inc. | P Buy deriv | 2024-04-08 | 2024-04-10 | 371,187 | — | $0 | 371,187 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2023-12-19 | 2023-12-21 | 175,525 | — | $0 | 1,656,789 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2023-10-31 | 2023-11-02 | 100,606 | — | $0 | 1,481,264 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2023-09-15 | 2023-09-19 | 552,263 | — | $0 | 1,380,658 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2023-08-11 | 2023-08-15 | 828,395 | — | $0 | 828,395 | SEC↗ |
| SVRA Savara Inc | P Buy | 2023-07-17 | 2023-07-19 | 333,333 | $3.00 | $1000.0K | 24,471,264 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2023-06-28 | 2023-06-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2023-06-22 | 2023-06-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2023-06-21 | 2023-06-23 | 14,000 | — | $0 | 14,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2023-06-21 | 2023-06-23 | 3,000 | — | $0 | 3,000 | SEC↗ |
| SNTI Senti Biosciences, Inc. | A Award deriv | 2023-06-16 | 2023-06-21 | 62,500 | — | $0 | 62,500 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2023-06-13 | 2023-06-15 | 16,000 | — | $0 | 16,000 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | A Award deriv | 2023-06-06 | 2023-06-08 | 17,500 | — | $0 | 17,500 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | J Other | 2023-03-02 | 2023-03-06 | 5,771 | — | $0 | 5,771 | SEC↗ |
| AKUS Akouos, Inc. | D To issuer deriv | 2022-12-01 | 2022-12-02 | 16,000 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2022-10-17 | 2022-10-19 | 100,000 | $1000.00 | $100.00M | 100,000 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2022-10-17 | 2022-10-19 | 37,700 | $1000.00 | $37.70M | 37,700 | SEC↗ |
| SNTI Senti Biosciences, Inc. | A Award deriv | 2022-07-13 | 2022-07-15 | 125,000 | — | $0 | 125,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2022-06-23 | 2022-06-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AKUS Akouos, Inc. | A Award deriv | 2022-06-23 | 2022-06-27 | 16,000 | — | $0 | 16,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2022-06-10 | 2022-06-14 | 9,367 | — | $0 | 9,367 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2022-06-09 | 2022-06-13 | 27,000 | — | $0 | 27,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2022-06-08 | 2022-06-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2022-06-02 | 2022-06-06 | 17,000 | — | $0 | 17,000 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | A Award deriv | 2022-06-01 | 2022-06-03 | 17,500 | — | $0 | 17,500 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2022-04-11 | 2022-04-13 | 3,000,000 | $1.90 | $5.70M | 3,000,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award | 2022-04-11 | 2022-04-13 | 948,948 | $1.90 | $1.80M | 948,948 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion deriv | 2021-06-28 | 2021-06-30 | 2,361,912 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion deriv | 2021-06-28 | 2021-06-30 | 11,500,000 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion deriv | 2021-06-28 | 2021-06-30 | 9,588,725 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | P Buy | 2021-06-28 | 2021-06-30 | 1,050,000 | $19.00 | $19.95M | 7,692,298 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion | 2021-06-28 | 2021-06-30 | 2,715,968 | — | $0 | 2,715,968 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion | 2021-06-28 | 2021-06-30 | 3,257,328 | — | $0 | 5,973,296 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion | 2021-06-28 | 2021-06-30 | 669,002 | — | $0 | 6,642,298 | SEC↗ |
| AKUS Akouos, Inc. | A Award deriv | 2021-06-24 | 2021-06-25 | 16,000 | — | $0 | 16,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2021-06-23 | 2021-06-24 | 9,367 | — | $0 | 9,367 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2021-06-10 | 2021-06-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2021-06-09 | 2021-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2021-06-09 | 2021-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2021-06-04 | 2021-06-08 | 17,000 | — | $0 | 17,000 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | A Award deriv | 2021-04-08 | 2021-04-12 | 14,000 | — | $0 | 14,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2020-07-23 | 2020-07-24 | 9,367 | — | $0 | 9,367 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2020-06-17 | 2020-06-18 | 18,500 | — | $0 | 18,500 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2020-06-11 | 2020-06-15 | 17,000 | — | $0 | 17,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2020-06-11 | 2020-06-15 | 14,210 | — | $0 | 14,210 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2020-06-04 | 2020-06-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 15,000 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 15,000 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 15,000 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2019-06-19 | 2019-06-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | A Award deriv | 2019-06-11 | 2019-06-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2019-06-05 | 2019-06-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2019-05-07 | 2019-05-08 | 23,684 | — | $0 | 23,684 | SEC↗ |
| LQDA Liquidia Technologies Inc | A Award deriv | 2018-07-25 | 2018-07-27 | 26,986 | — | $0 | 26,986 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | A Award deriv | 2018-06-28 | 2018-07-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2018-06-13 | 2018-06-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2018-06-06 | 2018-06-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2017-12-29 | 2018-01-03 | 18,572 | — | $0 | 18,572 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2017-08-28 | 2017-08-30 | 1,428 | — | $0 | 1,428 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | A Award deriv | 2017-06-20 | 2017-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | A Award deriv | 2016-06-29 | 2016-09-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | A Award deriv | 2015-09-30 | 2015-09-30 | 7,200 | — | $0 | 7,200 | SEC↗ |